LRRK2 and Parkinson disease: Although the current BoR score is based on limited data from a heterogeneous patient cohort and must be considered a first step towards a more comprehensive model, the score differentiated LRRK2 PD patients from controls with 79.7% accuracy, 81.3% sensitivity, 78.6% specificity, 74.3% precision and 83.0% AUC.